Sheldon Berkle has resigned  as president, chief executive officer, and member of the board of directors of  Altus Pharmaceuticals, Inc. (Cambridge,   MA). David D. Pendergast, PhD, has  been appointed to the interim position of executive chairman while the company  initiates a search for a new president and chief executive officer.

News

Sheldon Berkle has resigned as president, chief executive officer, and member of the board of directors of Altus Pharmaceuticals, Inc. (Cambridge, MA).